T(h)1-derived cytokine IFN-γ is a potent inhibitor of eotaxin synthesis in vitro

International Immunology

Volumn 11, Issue 6, 1999, Pages 1001-1004

  Miyamasu, Misato ^a   Yamaguchi, Masao ^a   Nakajima, Toshiharu ^a   Misaki, Yoshikata ^a   Morita, Yutaka ^a   Matsushima, Kouji ^a   Yamamoto, Kazuhiko ^a   Hirai, Koichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Allergy; ELISA; Eosinophil; Fibroblast; IL 4

Indexed keywords

EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA; BETA CHEMOKINE; CYTOKINE; EOSINOPHIL CHEMOTACTIC FACTOR;

ARTICLE; CONTROLLED STUDY; FIBROBLAST; HELPER CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; BIOSYNTHESIS; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SKIN; TH1 CELL;

CHEMOKINES, CC; CHEMOTACTIC FACTORS, EOSINOPHIL; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FIBROBLASTS; HUMANS; INTERFERON TYPE II; SKIN; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032587651     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.6.1001     Document Type: Article

References (19)

1. Garcia, Z. E., Rothenberg, M. E., Ownbey, R. T., Celestin, J., Leder, P. and Luster, A. D. 1996. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat. Med. 2:449.
2. Jose, P. J., Griffiths Johnson, D. A., Collins, P. D., Walsh, D. T., Moqbel, R., Totty, N. F., Truong, O., Hsuan, J. J. and Williams, T. J. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179:881.
3. Ponath, P. D., Qin, S., Post, T. W., Wang, J., Wu, L., Gerard, N. P., Newman, W., Gerard, C. and Mackay, C. R. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183:2437.
4. Heath, H., Qin, S., Rao, P., Wu, L., LaRosa, G., Kassam, N., Ponath, P. D. and Mackay, C. R. 1997. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest 99:178.
5. Yamada, H., Hirai, K., Miyamasu, M., Iikura, M., Y. Misaki, Y., Shoji, S., T. Takaishi, T., Kasahara, T., Morita, Y. and Ito, K. 1997. Eotaxin is a potent chemotaxin for human basophils. Biochem. Biophys. Res. Commun. 231:365.
6. Uguccioni, M., Mackay, C. R., Ochensberger, B., Loetscher, P., Rhis, S., LaRosa, G. J., Rao, P., Ponath, P. D., Baggiolini, M. and Dahinden, C. A. 1997. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J. Clin. Invest 100:1137.
7. Sallusto, F., Mackay, C. R. and Lanzavecchia, A. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005.
8. h2 paradigm. Immunol. Today 18:263.
9. Rothenberg, M. E., Luster, A. D. and Leder, P. 1995. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc. Natl Acad. Sci. USA 92:8960.
10. Mochizuki, M., Bartels, J., Mallet, A. I., Christophers, E. and Schröder, J.-M. 1998. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J. Immunol. 160:60.
11. + T cells. J. Exp. Med. 177:573.
12. Urban, J. J., Madden, K. B., Cheever, A. W., Trotta, P. P., Katona, I. M. and Finkelman, F. D. 1993. IFN inhibits inflammatory responses and protective immunity in mice infected with the nematode parasite Nippostrongylus brasiliensis. J. Immunol. 151:7086.
13. Kung, T. T., Stelts, D., Zurcher, J. A., Watnick, A. S., Jones, H., Mauser, P. J., Fernandez, X., Umland, S., Kreutner, W., Chapman, R. W. and Egan, R. W. 1994. Mechanisms of allergic pulmonary eosinophilia in the mouse. J. Allergy Clin. Immunol. 94:1217.
14. Yi, Y., James, L., Rolf-Peter, R., Daniel C. and Rodrigo, B. 1998. Antigen-induced eosinophilic lung inflammation develops in mice deficient in chemokine eotaxin. Blood 92:3912.
15. Hein, H., Schluter, C., Kulke, R., Christophers, E., Schröder, J. M. and Bartels, J. 1997. Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene. Biochem. Biophys. Res. Commun. 237:537.
16. Nakajima, T., Yamada, H., Iikura, M., Miyamasu, M., Izumi, S., Shida, H., Ohta, K., Imai, T., Yoshie, O., Mochizuki, M., Schröder, J.-M., Morita, Y., Yamamoto, K. and Hirai, K. 1998. Intracellular localization and release of eotaxin from normal eosinophils. FEBS Lett. 434:226.
17. Miyamasu, M., Hirai, K., Takahashi, Y., Iida, M., Yamaguchi, M., Koshino, T., Takaishi, T., Morita, Y., Ohta, K., Kasahara, T. and Ito, K. 1995. Chemotactic agonists induce cytokine generation in eosinophils. J. Immunol. 154:1339.
18. Izumi, S., Hirai, K., Miyamasu, M., Takahashi, Y., Misaki, Y., Takaishi, T., Morita, Y., Matsushima, K., Ida, N., Nakamura, H., Kasahara, T. and Ito, K. 1997. Expression and regulation of monocyte chemoattractant protein-1 by human eosinophils. Eur. J. Immunol. 27:816.
19. Miyamasu, M., Misaki, Y., Izumi, S., Takaishi, T., Motita, Y., Nakamura, H., Matsushima, K., Kasahara, T. and Hirai, K. 1998. Glucocorticoids inhibit chemokine generation by human eosinophils. J. Allergy Clin. Immunol. 101:75.